Andrea Moschopoulos
Psychiatric/Mental Health · Boston, MANPI 1326749730
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 381 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 32.5% of the total. 2025 is the largest year on record at $3,644, 2.6 times the $1,401 reported in 2023. Among psychiatric/mental health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 381 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3K
- Neurocrine Biosciences, Inc.$1K
- Lundbeck LLC$962
- Otsuka America Pharmaceutical, Inc.$803
- Teva Pharmaceuticals USA, Inc.$470
- Axsome Therapeutics, Inc.$250
- plus $2K from 13 others
What the payments were for
- Food & beverage$8,034100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 104 | $2,612 |
| Neurocrine Biosciences, Inc. | 44 | $1,346 |
| Lundbeck LLC | 63 | $962 |
| Otsuka America Pharmaceutical, Inc. | 53 | $803 |
| Teva Pharmaceuticals USA, Inc. | 25 | $470 |
| Axsome Therapeutics, Inc. | 16 | $250 |
| Johnson & Johnson | 7 | $231 |
| Collegium Pharmaceutical, Inc. | 14 | $215 |
| E.r. Squibb & Sons, L.L.C. | 8 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $183 |
| Corium, LLC | 8 | $169 |
| Vanda Pharmaceuticals Inc. | 7 | $159 |
| Alkermes, Inc. | 6 | $129 |
| Supernus Pharmaceuticals, Inc. | 9 | $120 |
| Tris Pharma Inc | 4 | $71 |
| Indivior Inc. | 2 | $49 |
| Braeburn Inc. | 2 | $39 |
| AbbVie | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$116
How this compares
$8,036 in reported general payments places this provider in the 95th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
See all psychiatric/mental health providers in Massachusetts →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 12 | $27,005 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $231 | $27,00512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
Other psychiatric/mental health in Boston
- Roosevelt LewisBoston$7K
- Dorota BorkiewiczBoston$5K
- Brianne LienkampMarion$121K
- Ashley BakerQuincy$54K
- Brian BanksPembroke$47K
- Anne-Margaret BotelhoMattapoisett$46K
- Matthew PeculisWalpole$41K
- Sherrie UrenaWorcester$21K
- Irina DauphineeHanover$18K
- Schree PettigrewNew Bedford$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.